JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 13 No. 12 908-915
© 1972 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drum, D. E.
Right arrow Articles by Christacopoulos, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drum, D. E.
Right arrow Articles by Christacopoulos, J. S.

Hepatic Scintigraphy in Clinical Decision Making

David E. Drum and Julia Sdougou Christacopoulos

Harvard Medical School and Peter Bent Brigham Hospital, Boston, Massachusetts

Correspondence: For reprints contact: David E. Drum, Div. of Nuclear Medicine, Shields Warren Radiation Laboratory, 50 Binney St., Boston, Mass. 02115.

ABSTRACT

The results of 650 liver scintiscans performed in a university teaching hospital have been analyzed with the aim of relating scintigraphic appearance to clinicopathological disease in the context of diagnostic management. Hepatic scintigraphy detected the presence of parenchymal, focal, or infiltrative disease with 90% accuracy. The various possible scintigraphic abnormalities, while by no means histologically diagnostic, occurred with probabilities distinctive for each disease category. Analysis of these data and the sources of erroneous interpretations in the light of signal detection theory leads to the conclusion that the pattern-reading methodology may inherently preclude further uncompensated improvement in a single aspect of clinical performance. This conclusion is supported by accuracy data already on record and it suggests that development of disease specific radiopharmaceutical agents merits high priority in research planning.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. H. Blackstone and M. S. Lauer
Caveat emptor: The treachery of work-up bias
J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 341 - 344.
[Full Text] [PDF]


Home page
Stat Methods Med ResHome page
X.-H. Zhou
Correcting for verification bias in studies of a diagnostic test's accuracy
Statistical Methods in Medical Research, August 1, 1998; 7(4): 337 - 353.
[Abstract] [PDF]


Home page
BMJHome page
D G Altman and J M Bland
Statistics Notes: Diagnostic tests 1: sensitivity and specificity
BMJ, June 11, 1994; 308(6943): 1552 - 1552.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1972 by the Society of Nuclear Medicine.